ArticleClinical and translational medicine2020

CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signaling.

Bo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.